A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)
Clinical trial NCT06980805 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06980805
- Sponsor
- Immunovant Sciences GmbH
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-19
- Primary completion
- 2026-10-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.